Mika K Derynck - Net Worth and Insider Trading

Mika K Derynck Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mika K Derynck owns 1 companies in total, including Enliven Therapeutics Inc (ELVN) .

Click here to see the complete history of Mika K Derynck’s form 4 insider trades.

Insider Ownership Summary of Mika K Derynck

Ticker Comapny Transaction Date Type of Owner
ELVN Enliven Therapeutics Inc 2023-02-23 director

Mika K Derynck Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mika K Derynck Ownership Network

Ownership Network List of Mika K Derynck

No Data

Ownership Network Relation of Mika K Derynck

Insider Network Chart

Mika K Derynck Owned Company Details

What does Enliven Therapeutics Inc do?

Who are the key executives at Enliven Therapeutics Inc?

Mika K Derynck is the director of Enliven Therapeutics Inc. Other key executives at Enliven Therapeutics Inc include director & Chief Scientific Officer Joseph P Lyssikatos , Chief Financial Officer Benjamin Hohl , and director & President and CEO Samuel Kintz .

Enliven Therapeutics Inc (ELVN) Insider Trades Summary

Over the past 18 months, Mika K Derynck made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 193,979 shares made by Samuel Kintz , a net sale of 177,099 shares made by Joseph P Lyssikatos , and a net sale of 62,991 shares made by Benjamin Hohl .

In summary, during the past 3 months, insiders sold 151,271 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 151,271 shares. During the past 18 months, 4,703,140 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,703,140 shares.

Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Enliven Therapeutics Inc Insider Transactions

No Available Data

Mika K Derynck Mailing Address

Above is the net worth, insider trading, and ownership report for Mika K Derynck. You might contact Mika K Derynck via mailing address: C/o Amunix Pharmaceuticals, Inc., 2 Tower Place, #1100, South San Francisco Ca 94080.

Discussions on Mika K Derynck

No discussions yet.